Structured around transforming how large biological datasets are harnessed to accelerate the identification and validation of new medicines, the twoXAR team is dedicated to improving health on a global scale by building a profit-generating business utilizing artificial intelligence. The co-founding team is from the Stanford School of Medicine and the MIT Sloan School of Management and was brought together by a common last name (though they are not related), entrepreneurial inclination and technology and have successfully attracted and recruited a powerful, highly experience team
